In the months leading up to his arrest, Shkreli became one of the most hated figures in America.
Martin Shkreli has stepped down from his post as CEO of Turing Pharmaceuticals, just one day after federal authorities charged the “bad boy” of biotech with securities fraud. Turing announced in a statement today the appointment of Ron Tilles to the position of interim chief executive officer.
